Target intelligence / Profile preview

Damaged tissues

Molecular classification
Other
01

Overview

Damaged tissues represent a pathological state or physical location where cellular and structural integrity has been compromised by trauma, ischemia, infection, or chronic disease rather than a specific molecular target. This environment is characterized by the release of Damage-Associated Molecular Patterns (DAMPs), which trigger an innate immune response and initiate the stages of wound healing: hemostasis, inflammation, proliferation, and remodeling. In clinical practice, damaged tissues are the focus of regenerative medicine and wound care, where therapies aim to accelerate natural repair mechanisms or replace lost cellular functions. Because 'damaged tissue' encompasses a complex milieu of various cells, extracellular matrix components, and signaling molecules, it does not fit the definition of a single therapeutic receptor or enzyme target. Pharmaceutical interventions often target specific pathways within this environment, such as growth factor receptors or inflammatory cytokines, to restore homeostasis and promote functional recovery.

Other names
Injured tissueLesioned tissueNecrotic tissueWounded tissueTissue trauma
02

Mechanism of action

Promotion of angiogenesis, stimulation of fibroblast proliferation, enzymatic debridement of necrotic debris, and modulation of the inflammatory microenvironment.

03

Biological functions

Tissue repairWound healingInflammationHemostasisRegenerationApoptosisNecrosis
04

Disease associations

TraumaChronic woundsIschemia-reperfusion injuryFibrosisInfectionInflammation
05

Safety considerations

Excessive scarring or fibrosisRisk of secondary infectionPotential for malignant transformation in chronic non-healing woundsSystemic toxicity from localized treatments
06

Interacting drugs

Becaplermin

4 more in the full profile.

07

Biomarkers

Lactate dehydrogenase (LDH)Creatine kinase (CK)High mobility group box 1 (HMGB1)C-reactive protein (CRP)Troponin (for cardiac tissue damage)

Beyond the preview

Go deeper on Damaged tissues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damaged tissues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call